Common blood pressure medication associated with poorer kidney outcomes in type 2 diabetes

Article excerpt

A new study presented at the 63rd ERA Congress found that a widely used class of blood pressure medications may worsen kidney outcomes in people with type 2 diabetes, even those already taking modern kidney-protective drugs. The research suggests that commonly prescribed antihypertensives could pose unexpected risks for diabetic patients, raising questions about medication protocols that have become standard in treatment. The finding complicates clinical practice for doctors managing diabetes-related kidney disease, since blood pressure control remains essential for these patients. Researchers stopped short of recommending immediate changes but flagged the need for closer monitoring and further investigation into which patients face the greatest risk.